Alsamman A, El Allali A, Mokhtar M, Al-Shamaa K, Nassar A, Mousa K
PLoS One. 2023; 18(9):e0291204.
PMID: 37729135
PMC: 10511070.
DOI: 10.1371/journal.pone.0291204.
Luengwilai K, Yu J, Jimenez R, Thitisaksakul M, Vega A, Dong S
Int J Mol Sci. 2022; 23(19).
PMID: 36232530
PMC: 9570051.
DOI: 10.3390/ijms231911229.
Balague-Dobon L, Caceres A, Gonzalez J
Brief Bioinform. 2022; 23(2).
PMID: 35211719
PMC: 8921734.
DOI: 10.1093/bib/bbac043.
Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj B, Robrecht S, Krzykalla J
Nat Commun. 2021; 12(1):5395.
PMID: 34518531
PMC: 8438057.
DOI: 10.1038/s41467-021-25403-y.
Poubel C, Boroni M, Emerenciano M
Blood Adv. 2021; 5(8):2075-2078.
PMID: 33877294
PMC: 8095146.
DOI: 10.1182/bloodadvances.2020003643.
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.
Dobson S, Garcia-Prat L, Vanner R, Wintersinger J, Waanders E, Gu Z
Cancer Discov. 2020; 10(4):568-587.
PMID: 32086311
PMC: 7122013.
DOI: 10.1158/2159-8290.CD-19-1059.
Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Iacobucci I, Wen J, Meggendorfer M, Choi J, Shi L, Pounds S
Nat Genet. 2019; 51(4):694-704.
PMID: 30926971
PMC: 6828160.
DOI: 10.1038/s41588-019-0375-1.
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.
Caprini E, Bresin A, Cristofoletti C, Helmer Citterich M, Tocco V, Scala E
Cell Death Dis. 2018; 9(12):1178.
PMID: 30518749
PMC: 6281581.
DOI: 10.1038/s41419-018-1212-7.
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
Wong J, Bryant V, Lamprecht T, Ma J, Walsh M, Schwartz J
JCI Insight. 2018; 3(14).
PMID: 30046003
PMC: 6124395.
DOI: 10.1172/jci.insight.121086.
The Genomics of Prostate Cancer: A Historic Perspective.
Rubin M, Demichelis F
Cold Spring Harb Perspect Med. 2018; 9(3).
PMID: 29712681
PMC: 6396342.
DOI: 10.1101/cshperspect.a034942.
CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays.
Windpassinger C, Piard J, Bonnard C, Alfadhel M, Lim S, Bisteau X
Am J Hum Genet. 2017; 101(3):391-403.
PMID: 28886341
PMC: 5591019.
DOI: 10.1016/j.ajhg.2017.08.003.
Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes.
de Rooij J, Branstetter C, Ma J, Li Y, Walsh M, Cheng J
Nat Genet. 2017; 49(3):451-456.
PMID: 28112737
PMC: 5687824.
DOI: 10.1038/ng.3772.
Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Liau W, Tan S, Ngoc P, Wang C, Tergaonkar V, Feng H
Leukemia. 2016; 31(8):1798-1807.
PMID: 28028313
PMC: 5529293.
DOI: 10.1038/leu.2016.392.
Genomic-Wide Analysis with Microarrays in Human Oncology.
Inaoka K, Inokawa Y, Nomoto S
Microarrays (Basel). 2016; 4(4):454-73.
PMID: 27600234
PMC: 4996403.
DOI: 10.3390/microarrays4040454.
Mutations in the genes for thyroglobulin and thyroid peroxidase cause thyroid dyshormonogenesis and autosomal-recessive intellectual disability.
Mittal K, Rafiq M, Rafiullah R, Harripaul R, Ali H, Ayaz M
J Hum Genet. 2016; 61(10):867-872.
PMID: 27305979
DOI: 10.1038/jhg.2016.62.
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.
DeBoer R, Koval G, Mulkey F, Wetzler M, Devine S, Marcucci G
Leuk Lymphoma. 2016; 57(10):2298-306.
PMID: 26892479
PMC: 5008253.
DOI: 10.3109/10428194.2016.1144881.
Identification of two novel mutations in CDHR1 in consanguineous Spanish families with autosomal recessive retinal dystrophy.
Nikopoulos K, Avila-Fernandez A, Corton M, Lopez-Molina M, Perez-Carro R, Bontadelli L
Sci Rep. 2015; 5:13902.
PMID: 26350383
PMC: 4642573.
DOI: 10.1038/srep13902.
Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: a Connectivity Mapping analysis and an experimental study.
Zhuo W, Zhang L, Zhu Y, Xie Q, Zhu B, Chen Z
Am J Cancer Res. 2015; 5(7):2202-11.
PMID: 26328250
PMC: 4548331.
Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.
Shen J, LeFave C, Sirosh I, Siegel A, Tycko B, Santella R
BMC Med Genomics. 2015; 8:28.
PMID: 26059414
PMC: 4460673.
DOI: 10.1186/s12920-015-0105-1.
Loss of PCLO function underlies pontocerebellar hypoplasia type III.
Ahmed M, Chioza B, Rajab A, Schmitz-Abe K, Al-Khayat A, Al-Turki S
Neurology. 2015; 84(17):1745-50.
PMID: 25832664
PMC: 4424132.
DOI: 10.1212/WNL.0000000000001523.